Hazel Ross
Consultant Clinical Pharmacokinetics at Venn Life Sciences- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Venn Life Sciences - part of hVIVO plc
-
United Kingdom
-
Research
-
1 - 100 Employee
-
Consultant Clinical Pharmacokinetics
-
Jun 2020 - Present
-
-
-
Quotient Sciences
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Pharmacokineticist
-
Apr 2017 - Jun 2020
Lead scientist for pharmacokinetic (PK) aspects of human clinical trials Liaise with internal and external stakeholders across multiple disciplines to ensure client requirements are met Present pharmacokinetic data to clients and medical teams Provide training and mentoring support to junior members of staff Approve internal documents required for planning, analysis and reporting of PK and pharmacodynamic (PD) data Author and review PK and PD sections of clinical study reports Analyse PK and PD data using noncompartmental analysis (NCA) techniques Show less
-
-
-
Elanco
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Associate Consultant (Metabolism and Pharmacokinetics)
-
May 2016 - Mar 2017
Provided expert support to veterinary drug development teams by designing PK studies, analysing bioanalytical and PK data, and outlining required PK studies for companion animal parasiticide programs. Authored and reviewed protocols, reports and regulatory submission documents (FDA and EMA). Provided expert support to veterinary drug development teams by designing PK studies, analysing bioanalytical and PK data, and outlining required PK studies for companion animal parasiticide programs. Authored and reviewed protocols, reports and regulatory submission documents (FDA and EMA).
-
-
-
Covance
-
United States
-
Research Services
-
700 & Above Employee
-
Senior Pharmacokineticist
-
Nov 2010 - Mar 2016
Consulted with clients on development of small molecules through pre-clinical and phase I/II clinical trials, specializing in preclinical DMPK and clinical pharmacology Prepared DMPK and pharmacokinetic aspects of regulatory dossiers in support of drug development activities. Worked directly with clients on multidisciplinary project teams Designed, analyzed and reported preclinical toxicokinetic/pharmacokinetic studies and clinical Phase 1 studies Consulted with clients on development of small molecules through pre-clinical and phase I/II clinical trials, specializing in preclinical DMPK and clinical pharmacology Prepared DMPK and pharmacokinetic aspects of regulatory dossiers in support of drug development activities. Worked directly with clients on multidisciplinary project teams Designed, analyzed and reported preclinical toxicokinetic/pharmacokinetic studies and clinical Phase 1 studies
-
-
-
Sanofi
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Pharmacokineticist
-
Mar 2006 - Nov 2010
-
-
-
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
-
Hospitals and Health Care
-
700 & Above Employee
-
Medical Information Scientist
-
Feb 2005 - Mar 2006
-
-
-
Sanofi
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Research Scientist (DMPK)
-
Jul 2002 - Feb 2005
-
-
Education
-
The University of Sheffield
BSc. Hons Class 1, Pharmacology